Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9055)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2015 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pang Q, Qu K, Bi JB, Liu SS, Zhang JY, Song SD, Lin T, Xu XS, Wan Y, Tai MH, Liu HC, Dong YF, Liu C. Thrombocytopenia for prediction of hepatocellular carcinoma recurrence: Systematic review and meta-analysis. World J Gastroenterol 2015; 21(25): 7895-7906 [PMID: PMC4491977 DOI: 10.3748/wjg.v21.i25.7895] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i25/7895.htm |
| Number | Citing Articles |
| 1 |
Shuanggang Chen, Weimei Ma, Lujun Shen, Ying Wu, Han Qi, Fei Cao, Tao Huang, Weijun Fan. Recurrence Beyond the Milan Criteria of HBV-Related Single Hepatocellular Carcinoma of 2–3 cm: Comparison of Resection and Ablation. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.757149
|
| 2 |
Zhaohui Wang, Huiling Fu, Wei Li. Association between AKT rs2494752 single nucleotide polymorphism and the risk of metastasis in hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9060
|
| 3 |
Shuanggang Chen, Han Qi, Hongtong Tan, Fei Cao, Lin Xie, Tao Huang, Ying Wu, Chunyong Wen, Yujia Wang, Lujun Shen, Weijun Fan. Long-Term Analysis of Recurrence Beyond Milan Criteria Following Ablation of Solitary Early-Stage Hepatocellular Carcinoma ≤3 cm in Potentially Transplantable Patients: A Over 10-Year Survival Study. Journal of Hepatocellular Carcinoma 2025; : 205 doi: 10.2147/JHC.S505979
|
| 4 |
Zhong-Ran Man, Xuan-Kun Gong, Kang-Lin Qu, Qing Pang, Bin-Quan Wu. Albumin–bilirubin grade as a predictor of survival in hepatocellular carcinoma patients with thrombocytopenia. World Journal of Gastrointestinal Oncology 2024; 16(5): 1763-1772 doi: 10.4251/wjgo.v16.i5.1763
|
| 5 |
Severin Gylstorff, Vanessa Wilke, Daniel Kraft, Jessica Bertrand, Maciej Pech, Florian Haag, Borna Relja. Selective Internal Radiotherapy Alters the Profiles of Systemic Extracellular Vesicles in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(15): 12512 doi: 10.3390/ijms241512512
|
| 6 |
Mengxia Wang, Bo Zhuang, Shian Yu, Gang Li. Ensemble learning enhances the precision of preliminary detection of primary hepatocellular carcinoma based on serological and demographic indices. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1397505
|
| 7 |
Yang Zhang, Fangfang Jin, Yuan Wu, Bingyu Wang, Jingri Xie, Yu Li, Yujia Pan, Zhaolan Liu, Wenjuan Shen. Prognostic impact of gamma-glutamyl transpeptidase to platelets ratio on hepatocellular carcinoma patients who have undergone surgery: a meta-analysis and systematic review. European Journal of Gastroenterology & Hepatology 2023; 35(8): 803 doi: 10.1097/MEG.0000000000002572
|
| 8 |
Huiwen Yan, Dongdong Zhou, Xiaoli Liu, Peng Wang, Tingting Jiang, Zhiyun Yang. Survival analysis of patients with hepatocellular carcinoma based on the ratio of platelet count to spleen diameter. Frontiers in Pharmacology 2025; 15 doi: 10.3389/fphar.2024.1449603
|
| 9 |
Wen-juan Huang, Guang-yu Wang, Zeng-yao Liu, Meng-lin Zhang, Wen Wang, Xin Zhang, Rui-tao Wang. Preoperative PDW levels predict pulmonary metastasis in patients with hepatocellular carcinoma. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09754-3
|
| 10 |
Junhui Yang, Yunjie Zhang, Yifan Kong, Jiawei Lin, Guoqing Zhu, Hao Zhang, Zhijie Yu, Pixu Liu, Jinglin Xia. Diagnostic value of serum inflammatory markers in predicting early refractoriness of transarterial chemoembolization in patients with Barcelona Clinic Liver Cancer Stage 0, A, and B hepatocellular carcinoma. Brazilian Journal of Medical and Biological Research 2024; 57 doi: 10.1590/1414-431x2024e13661
|
| 11 |
Benoît Allignet, Pierre Pradat, Françoise Mornex, Floriane Izarn, Agnès Rode, Jean-Yves Mabrut, Kayvan Mohkam, Philippe Merle. Surgical resection versus transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma. Strahlentherapie und Onkologie 2023; 199(3): 293 doi: 10.1007/s00066-022-02022-0
|
| 12 |
Marek Kos, Piotr Tomaka, Paulina Mertowska, Sebastian Mertowski, Julia Wojnicka, Anna Błażewicz, Ewelina Grywalska, Krzysztof Bojarski. The Many Faces of Immune Thrombocytopenia: Mechanisms, Therapies, and Clinical Challenges in Oncological Patients. Journal of Clinical Medicine 2024; 13(22): 6738 doi: 10.3390/jcm13226738
|
| 13 |
Myung Ji Goh, Joo Hyun Oh, Yewan Park, Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik. Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea. Liver Cancer 2021; 10(1): 52 doi: 10.1159/000512239
|
| 14 |
Mauro Giuffrè, Enrico Zuliani, Alessia Visintin, Paola Tarchi, Paola Martingano, Riccardo Pizzolato, Deborah Bonazza, Flora Masutti, Rita Moretti, Lory Saveria Crocè. Predictors of Hepatocellular Carcinoma Early Recurrence in Patients Treated with Surgical Resection or Ablation Treatment: A Single-Center Experience. Diagnostics 2022; 12(10): 2517 doi: 10.3390/diagnostics12102517
|
| 15 |
Quirino Lai, Alessandro Vitale, Tommaso Manzia, Francesco Foschi, Giovanni Levi Sandri, Martina Gambato, Fabio Melandro, Francesco Russo, Luca Miele, Luca Viganò, Patrizia Burra, Edoardo Giannini. Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics. Cancers 2019; 11(10): 1568 doi: 10.3390/cancers11101568
|
| 16 |
Qing Pang, Shuangchi Liu, Luyao Wang, Huadong Pan, Chunfang Wang, Lei Zhou, Yimin Lu, Huichun Liu. <p>The Significance of Platelet–Albumin–Bilirubin (PALBI) Grade in Hepatocellular Carcinoma Patients Stratified According to Platelet Count</p>. Cancer Management and Research 2020; : 12811 doi: 10.2147/CMAR.S277013
|
| 17 |
A Mehrabi, M Golriz, E Khajeh, O Ghamarnejad, P Probst, H Fonouni, S Mohammadi, K H Weiss, M W Büchler. Meta-analysis of the prognostic role of perioperative platelet count in posthepatectomy liver failure and mortality. British Journal of Surgery 2018; 105(10): 1254 doi: 10.1002/bjs.10906
|
| 18 |
Jun-Yi Shen, Chuan Li, Tian-Fu Wen, Lv-Nan Yan, Bo Li, Wen-Tao Wang, Jia-Yin Yang, Ming-Qing Xu, Tholakkara Nazar Highness. Liver transplantation versus surgical resection for HCC meeting the Milan criteria. Medicine 2016; 95(52): e5756 doi: 10.1097/MD.0000000000005756
|
| 19 |
Shuanggang Chen, Weimei Ma, Fei Cao, Lujun Shen, Han Qi, Lin Xie, Ying Wu, Weijun Fan. Hepatocellular Carcinoma Within the Milan Criteria: A Novel Inflammation-Based Nomogram System to Assess the Outcomes of Ablation. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01764
|
| 20 |
Weijuan Cao, Xiaomin Yao, Danwei Cen, Yajun Zhi, Ningwei Zhu, Liyong Xu. Prognostic role of pretreatment thrombocytosis on survival in patients with cervical cancer: a systematic review and meta-analysis. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1676-7
|
| 21 |
Adem Deligonul, Secil Aksoy, Gulcin Tezcan, Berrin Tunca, Ozkan Kanat, Erdem Cubukcu, Tuncay Yilmazlar, Ersin Ozturk, Unal Egeli, Gulsah Cecener, Adem Alemdar, Turkkan Evrensel. DPYDc.1905 + 1G>A Promotes Fluoropyrimidine-Induced Anemia, a Prognostic Factor in Disease-Free Survival, in Colorectal Cancer. Genetic Testing and Molecular Biomarkers 2021; 25(4): 276 doi: 10.1089/gtmb.2020.0285
|
| 22 |
Qian Cheng Du, Chen Liang Hu, Yan Yan Wang, Ying Zhou. Comparison of the prognostic value of platelet-based prognostic models in patients with malignant hepatic tumors after TACE therapy. Acta Cirurgica Brasileira 2019; 34(7) doi: 10.1590/s0102-865020190070000010
|
| 23 |
Luca Rinaldi, Maria Guarino, Alessandro Perrella, Pia Clara Pafundi, Giovanna Valente, Luca Fontanella, Riccardo Nevola, Barbara Guerrera, Natalina Iuliano, Michele Imparato, Alessio Trabucco, Ferdinando Carlo Sasso, Filomena Morisco, Antonio Ascione, Guido Piai, Luigi Elio Adinolfi. Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience. Digestive Diseases and Sciences 2019; 64(10): 3013 doi: 10.1007/s10620-019-05604-8
|
| 24 |
Shuai Wang, Yan Deng, Xiao Yu, Xue-Wen Zhang, Cheng-Long Huo, Zhen-Gang Sun, Hong Chang. Prognostic significance of preoperative systemic inflammatory biomarkers in patients with hepatocellular carcinoma after microwave ablation and establishment of a nomogram. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93289-3
|
| 25 |
Riccardo Nevola, Rachele Ruocco, Livio Criscuolo, Angela Villani, Maria Alfano, Domenico Beccia, Simona Imbriani, Ernesto Claar, Domenico Cozzolino, Ferdinando Carlo Sasso, Aldo Marrone, Luigi Elio Adinolfi, Luca Rinaldi. Predictors of early and late hepatocellular carcinoma recurrence. World Journal of Gastroenterology 2023; 29(8): 1243-1260 doi: 10.3748/wjg.v29.i8.1243
|
| 26 |
Gundula Streubel, Sabine Schrepfer, Hannah Kallus, Ulrike Parnitzke, Tanja Wulff, Frank Hermann, Matthias Borgmann, Svetlana Hamm. Histone deacetylase inhibitor resminostat in combination with sorafenib counteracts platelet-mediated pro-tumoral effects in hepatocellular carcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-88983-1
|
| 27 |
Amr Shaaban Hanafy, Mohamed Sorour Mohamed, Ahmed A. Alnagar. Ascitic Calprotectin as an early predictor of hepatocellular carcinoma in patients with cirrhotic ascites. Journal of Cancer Research and Clinical Oncology 2020; 146(12): 3207 doi: 10.1007/s00432-020-03363-y
|